scout

Shorts

Meet the team behind the articles, interviews, and shorts posted on CancerNetwork and published in ONCOLOGY.
0:36
Meet The CancerNetwork Team
2 months ago
by
Cancer Network Staff
Patrick Borgen, MD, discussed the impact that MRD and ctDNA have played on treatment selection for breast cancer, particularly regarding surgery.
1:17
Examining the Impact of ctDNA on Breast Cancer Surgery
2 months ago
by
Patrick I. Borgen, MD
Patient-Centered Care Should Drive Sarcoma Research
0:50
Patient-Centered Care Should Drive Sarcoma Research
2 months ago
by
Emily J. Papai, MD
Suzann Duan, PhD, discussed the potential link between immunosenescence and the emergence of immunologically “cold” tumor microenvironments in GEP-NETS.
1:21
Is There a Link Between Immunosenescence and “Immune Cold” TMEs in NETs?
2 months ago
by
Suzann Duan, PhD
In a discussion with CancerNetwork®, Ram Prakash Thirugnanasambandam, MBBS, spoke about a manuscript he published in the November/December 2025 issue of the journal ONCOLOGY® focusing on the role that artificial intelligence (AI) can play in palliative care and hematologic malignancies.
0:55
Implementing AI as a Supportive Tool in Palliative Oncological Care
2 months ago
by
Ram Prakash Thirugnanasambandam, MBBS
Mauro Cives, MD, discussed a surprising finding in his research, which won an investigator award from the Neuroendocrine Tumor Research Foundation.
1:07
Some TILs May Exploit Antitumor Activity in Pancreatic NETs
2 months ago
by
Mauro Cives, MD
Shambavi Richard, MD, spoke with CancerNetwork® about findings from the phase 1b portion of the DURGA-1 trial (NCT05850234) assessing AZD0120, a novel BCMA/CD19 dual-targeting cellular therapy, among those with relapsed/refractory multiple myeloma.
0:39
AZD0120 Shows “Excellent” Response Rates in R/R Multiple Myeloma
2 months ago
by
Shambavi Richard, MD
Dominique Rash, MD, highlighted what patient factors and characteristics guide how radiation oncologists coordinate utilizing radiation with systemic therapy for patients with inoperable endometrial cancer.
0:56
Sequencing Radiation With Systemic Therapy in Inoperable Endometrial Cancer
2 months ago
by
Dominique Rash, MD
Why Survivorship is the Next Phase of Cancer Research
0:41
Why Survivorship is the Next Phase of Cancer Research
2 months ago
by
Fumiko Chino, MD
In a conversation with CancerNetwork® at the 2026 American College of Radiation Oncology (ACRO) Summit, Pranshu Mohindra, MD, discussed the evolution of hypofractionated radiotherapy in the lung cancer field, which may help expedite the treatment process for patients
0:46
How Has Hypofractionation Made Lung Cancer Radiotherapy More Convenient?
2 months ago
by
Pranshu Mohindra, MD
Monzr M. Al Malki, MD, described TRX103, an off-the-shelf allogenic T-cell therapy, contextualized by a presentation he gave at the 2026 Tandem Meetings.
0:42
TRX103: The Future of Allogeneic T-Cell Therapy?
2 months ago
by
Monzr Al Malki, MD
When to Use Checkpoint Inhibitors in Sarcoma Therapy
1:27
When to Use Checkpoint Inhibitors in Sarcoma Therapy
2 months ago
by
Seth M. Pollack, MD
Vanessa Almendro Navarro, PhD, MBA, encourages her colleagues to envision an ideal state of City of Hope as an organization as opposed to succumbing to the fear of change.
0:57
Overcoming Fear to Change in the Commercialization Aspect of Oncology
2 months ago
by
Vanessa Almendro Navarro, PhD, MBA
Irtiza N. Sheikh, DO, touched upon key questions that emerged following the publication of research evaluating liso-cel between patients younger than 50 and those 50 years and older in both the real-world and clinical trial settings.
1:13
Highlighting Key Questions in Liso-Cel Treatment Across Lymphoma Settings
2 months ago
by
Irtiza N. Sheikh, DO
Vanessa Almendro Navarro, PhD, MBA, highlighted the importance of collaboration between oncology departments to facilitate drug development for use in oncology care.
1:14
Collaboration Across Departments is Key in Oncology Development
2 months ago
by
Vanessa Almendro Navarro, PhD, MBA
Looking back at the long-term effects of the COVID-19 pandemic on oncology care, Daniel C. McFarland, DO, spoke with CancerNetwork® about how this health crisis impacted his interactions with patients from a psycho-oncology perspective.
0:36
COVID-19 Was ‘Added Layer of Trauma’ in Psycho-Oncology Care
2 months ago
by
Daniel C. McFarland, DO
Personalizing Diet Based on Patient Risk and Metabolism
0:49
Personalizing Diet Based on Patient Risk and Metabolism
2 months ago
by
Ifeoma Dikeocha, PhD
Irtiza N. Sheikh, DO, discussed key efficacy findings from a comparative analysis of liso-cel among patients younger than 50 with large B-cell lymphoma (LBCL) in the real-world and clinical trial settings.
0:50
Data Show Similar Liso-Cel Efficacy in Young LBCL Groups Across Settings
2 months ago
by
Irtiza N. Sheikh, DO
The Missing Link in Cancer Research: Diversity
0:38
The Missing Link in Cancer Research: Diversity
2 months ago
by
Kathie-Ann Joseph, MD, MPH, FACS
A study published in Lancet Oncology demonstrated that radiation is a feasible method to treat celiac plexus-associated pain in patients with gastrointestinal cancers.
0:57
Using Radiation to Treat Celiac Plexus-Associated Pain in GI Cancers
2 months ago
by
Michael Buckstein, MD, PhD
Revolutionizing Breast Cancer: From 7 Weeks to 1 Week of Radiation
0:53
Revolutionizing Breast Cancer: From 7 Weeks to 1 Week of Radiation
2 months ago
by
Parul Barry
Beyond Mastectomy: The Power of Oncoplastic Surgery
0:38
Beyond Mastectomy: The Power of Oncoplastic Surgery
2 months ago
by
Kathie-Ann Joseph, MD, MPH, FACS
ACRO Day 2 Quick Take With CancerNetwork
1:52
ACRO Day 2 Quick Take With CancerNetwork
2 months ago
by
Ariana Pelosci(+1 more)
The Complex Decisions in Treating DCIS Breast Cancer
0:43
The Complex Decisions in Treating DCIS Breast Cancer
2 months ago
by
Jean L. Wright, MD, FASTRO
Yun Rose Li, MD, PhD, spoke about the inspiration behind her team’s assessment of cardiovascular risks with hormone therapy for prostate cancer in the phase 2 IMPACT-ADT trial.
1:27
STEMI Event Inspires Prostate Cancer Trial Assessing Cardiovascular Risk
2 months ago
by
Yun Rose Li, MD, PhD
As part of a conversation with a CancerNetwork®, Manoj Bhasin, PhD, MS, discussed the next steps for refining the development of next-generation therapies for patients with newly diagnosed multiple myeloma (NDMM) following novel translational findings that he and colleagues published in Nature Cancer.
0:48
Translating Cytogenetic Data Into Next-Generation Therapies in NDMM
2 months ago
by
Manoj Bhasin, PhD, MS
ACRO Day 1 Quick Take With CancerNetwork
0:48
ACRO Day 1 Quick Take With CancerNetwork
2 months ago
by
Ariana Pelosci(+1 more)
Yun Rose Li, MD, PhD, discussed a balancing act when considering treatment with hormone therapy for patients with late-stage prostate cancer, particularly those who are at a higher risk of cardiovascular events.
1:06
Balancing Cardiovascular and Prostate Cancer Risks in Oncology Treatment
2 months ago
by
Yun Rose Li, MD, PhD
In honor of World Cancer Day, Paolo Tarantino, MD, spoke with CancerNetwork® about the current state of the oncology field and how it may continue to evolve.
0:51
Social Media and AI Are Expanding With the Data in Oncology Research
2 months ago
by
Paolo Tarantino, MD, PhD
How Can Diet Improve Chemotherapy Results?
1:01
How Can Diet Improve Chemotherapy Results?
2 months ago
by
Ifeoma Dikeocha, PhD